Intra-articular Tranexamic Acid

PreclinicalSmall molecule

Intra-articular Tranexamic Acid is one of 7 small molecule programs targeting Knee Arthroplasty. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Knee ArthroplastyCompleted

Knee ArthroplastyPreclinical

Completed

Competition

Competitive Landscape

6 competitors in Knee Arthroplasty

#DrugCompanyPhaseTrials

Decadron

AAspen Global Incorporated

Approved

3 2

Precedex

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Approved

2 3

EXPAREL

Pacira Pharmaceuticals, Inc

Approved

1 4

Intrathecal Morphine

Pacira Pharmaceuticals, Inc

Preclinical

1 5

Intrathecal Fentanyl

MMansoura University

Preclinical

1 6

Intra-articular Tranexamic Acid

IIdlib University

Preclinical

1 7

Intra Thecal Morphine

UUniversity College Hospital Galway

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Knee Arthroplasty1 trial

Tranexamic Acid and Drain Use in Knee Arthroplasty

Completed·IIdlib University·N/A·NCT07174895·192 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Intra-articular Tranexamic Acid. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Intra-articular Tranexamic Acid compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Intra-articular Tranexamic Acid. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Idlib University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: IIdlib University

Intra-articular Tranexamic Acid

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Knee Arthroplasty1 trial

References

Drug Info

Quick Facts

Related News